• Right now, concentration is your portfolio’s biggest threat. Learn why here.

SkinKandy’s FY26 maiden result

SkinKandy’s FY26 maiden result

SkinKandy (ASX: SK1) is Australia and New Zealand’s self-proclaimed leading specialty piercing and body jewellery retailer. Operating a ‘service-led retail model,’ the company delivers over 60 distinct types of professional body and ear piercings alongside a range of high-margin jewellery and specialised aftercare products.

Body and multi-ear piercings have shifted from niche subcultures into mainstream fashion, accelerated by social media and expanding demographic participation among both male and female consumers.

Because piercing is an experiential, service-driven purchase, the company benefits from a foot-traffic driver that e-commerce cannot replicate, positioning SkinKandy alongside hair, nail, and makeup categories in experiential brick-and-mortar retail.

Financial performance

In its inaugural full-year result post initial public offering (IPO), SkinKandy delivered a strong beat across key operational and financial metrics. FY26 underlying Net Profit After Tax (NPAT) beat expectations and guidance by around five per cent, primarily driven by stronger-than-expected top-line performance.

Like-for-Like (LFL) sales growth reached +9.6 per cent, comfortably ahead of guidance (+8.1 per cent).

Total sales beat guidance by +2 per cent, supported by reaching 109 stores at year-end (exceeding prospectus guidance of 108).

Cost of Doing Business (CODB) as a percentage of sales fell -289 bps year-on-year to 61.9 per cent, outperforming the 62.8 per cent guided target.

Operating cash conversion strengthened to 101 per cent (up from 92 per cent in FY25), leaving the company with $13.8 million in net cash (including $6 million in term deposits), beating broker expectations by +20 per cent.

The only slight negative was the higher Depreciation & Amortisation (D&A) – which came in 7 per cent higher than forecast – and management’s decision to phase out short-term trading updates.

Growth outlook

Trading momentum has continued into the start of the new financial year. Total sales across the first seven weeks of FY27 surged +22 per cent, aligning with Visible Alpha (VA) 1H27 consensus expectations. Strong LFL momentum continued from Q4 (~7.3 per cent) into early FY27, keeping performance on track with board targets.

Strategic metric

FY27 guidance

Market consensus / prior target

Focus / highlights

ANZ store openings

18–20

17

Upper end of 15–20 long-term target (10–14 expected in 1H27)

International footprint

2H27 Launch

Target entry

South Africa identified as likely debut offshore market

Downsizing fee trial

Retained ($15 / $10)

Monetization lever

Trial successful ($15 non-loyalty / $10 loyalty); provides material FY27 NPAT upside

According to broker Barrenjoey, the trial of a dedicated downsizing fee for post-piercing care has proven highly successful and will remain permanent. Charging $15 for non-loyalty members and $10 for loyalty members unlocks a significant LFL monetisation lever, representing a potential +21 per cent upside to existing FY27 NPAT projections if fully realised across the network.

Given the top-to-bottom beat on FY26 underlying NPAT, robust early FY27 trading momentum, aggressive store-rollout plans, and clear international growth execution, the stock appears positioned to re-rate.

Trends and risks

Despite SkinKandy’s stellar growth, long-term investors have to grapple with the inherent cyclicality, saturation and fast-fashion risks of body modification.

The current boom in multi-ear piercings – often framed as the “curated ear” – has benefited from a multi-year fashion adoption curve, but history demonstrates that bodily adornments are inherently subject to trend fatigue.

Much like the tattoo boom of the 2010s or various fleeting hairstyle crazes, body piercing risks reaching a natural upper limit of consumer canvas space. Once a customer’s ears are fully styled, repeat service revenue naturally decelerates. 

Furthermore, younger cohorts, such as Generation Alpha, often oppose the style trends of the generations before them, thereby posing a key demographic risk. Emerging consumer behaviour research indicates that younger generations increasingly favour identity-first, non-permanent self-expression, actively resisting the uniform visual trends popularised by Gen Z.

If younger consumers pivot away from ‘hardware’ toward alternative aesthetic statements, SkinKandy’s core business model risks being a “one-trick pony” tied to a peak fashion trend.

 

Coupled with rising price sensitivity among youth demographics and the physical risk of piercing-complication fatigue, any structural decline in foot traffic could quickly squeeze margins, given the high fixed-cost footprint of a store network.

Disclaimer:

The Montgomery Small Companies Fund owns shares in SK1. This article was prepared 25 August 2026 with the information we have today, and our view may change. Itdoes not constituteformal advice or professional investment advice. If you wish to trade SK1, you should seek financial advice. 

INVEST WITH MONTGOMERY

Roger Montgomery is the Founder and Chairman of Montgomery Investment Management. Roger has over three decades of experience in funds management and related activities, including equities analysis, equity and derivatives strategy, trading and stockbroking. Prior to establishing Montgomery, Roger held positions at Ord Minnett Jardine Fleming, BT (Australia) Limited and Merrill Lynch.

He is also author of best-selling investment guide-book for the stock market, Value.able – how to value the best stocks and buy them for less than they are worth.

Roger appears regularly on television and radio, and in the press, including ABC radio and TV, The Australian and Ausbiz. View upcoming media appearances. 

This post was contributed by a representative of Montgomery Investment Management Pty Limited (AFSL No. 354564). The principal purpose of this post is to provide factual information and not provide financial product advice. Additionally, the information provided is not intended to provide any recommendation or opinion about any financial product. Any commentary and statements of opinion however may contain general advice only that is prepared without taking into account your personal objectives, financial circumstances or needs. Because of this, before acting on any of the information provided, you should always consider its appropriateness in light of your personal objectives, financial circumstances and needs and should consider seeking independent advice from a financial advisor if necessary before making any decisions. This post specifically excludes personal advice.

Why every investor should read Roger’s book VALUE.ABLE

NOW FOR JUST $49.95

find out more

SUBSCRIBERS RECEIVE 20% OFF WHEN THEY SIGN UP


Leave a reply

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong> 

required